Among these subunits, we demonstrated that ATP6AP2 was downregulated in therapy-induced senescent breast cancer cells, causing intracellular acidification (reduction in pHi) and lysosomal alkalinization (elevation in pHL). This evidence concerns the gene ATP6AP2 and breast cancer.